Home LiteratureArticle Details
PMID: 830309 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Cardiovascular birth defects and antenatal exposure to female sex hormones.

The New England journal of medicine ·Vol. 296 ·No. 2 ·1977-01-13 ·Pages 67-70

Heinonen OP, Slone D, Monson RR, Hook EB, Shapiro S

Abstract

In a cohort of 50,282 pregnancies 19 children with cardiovascular defects were born to 1042 women who received female hormones during early pregnancy (18.2 per 1000). Among 49,240 children not exposed in utero to these agents there were 385 with cardiovascular malformations (7.8 per 1000). Six children with cardiovascular defects were born to a sub-group of 278 women who used oral contraceptives during early pregnancy (21.5 per 1000). After the data were controlled for a wide variety of potentially confounding factors by multivariate methods, the association between in utero exposure to female hormones and cardiovascular birth defects was statistically significant.

MeSH Terms
Adult Contraceptives, Oral, Synthetic/adverse effects Diethylstilbestrol/adverse effects Estradiol Congeners/adverse effects Female Gestational Age Heart Defects, Congenital/chemically induced Humans Infant, Newborn Maternal-Fetal Exchange Mestranol/adverse effects Pregnancy Progesterone Congeners/adverse effects Risk
Chemicals
Contraceptives, Oral, Synthetic Estradiol Congeners Progesterone Congeners Diethylstilbestrol Mestranol
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Heinonen O P
Slone D
Monson R R
Hook E B
Shapiro S
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1977-01-13
Pages
67-70
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]